October 26, 2008

May 26, 2008

May 28, 2008

February 27, 2008

March 23, 2007

 

February 9, 2007

January 18, 2007

December 20, 2006

 

 

 

MuriGen restructures G-CSF antagonist program with CSL

NEW CANCER TARGET IDENTIFIED

RESEARCHERS AT WEHI PINPOINT THE FUNCTION OF A POTENT CANCER GENE

MURIGEN PARTNER ENTERS COLLABORATION AGREEMENT WITH ABBOTT

MAJOR DISCOVERY RAISES PROSPECT OF BETTER PATIENT CARE BY IMPROVING PLATELET LIFE SPAN

MURIGEN PARTNER ENTERS COLLABORATION AGREEMENT WITH GENENTECH

MURIGEN TO BENEFIT FROM $32.55 MILLION FEDERAL GOVERNMENT GRANT

MURIGEN THERAPEUTICS ANNOUNCES INVESTMENT BY STARFISH VENTURES